LEADER 01623nam  2200469   450 
001 9910480251403321
010   $a0-309-46264-9
035   $a(CKB)4340000000215693
035   $a(MiAaPQ)EBC5109491
035   $a(EXLCZ)994340000000215693
100   $a20171122h20172017  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aEnabling precision medicine $ethe role of genetics in clinical drug development : proceedings of a workshop /$fMorgan L. Boname [and four others], rapporteurs
210  1$aWashington, District of Columbia :$cThe National Academies Press,$d2017.
210  4$dİ2017
215   $a1 online resource (122 pages) $cillustrations (some color)
311   $a0-309-46263-0 
320   $aIncludes bibliographical references.
606   $aDrug development$vCongresses
606   $aPersonalized medicine$vCongresses
606   $aPharmacogenetics$vCongresses
608   $aElectronic books.
615  0$aDrug development
615  0$aPersonalized medicine
615  0$aPharmacogenetics
676   $a615.190072
702   $aBoname$b Morgan L.
712 02$aInstitute of Medicine (U.S.).$bForum on Drug Discovery, Development, and Translation.
712 02$aRoundtable on Genomics and Precision Health.
712 02$aBoard on Health Sciences Policy.
712 02$aHealth and Medicine Division.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910480251403321
996   $aEnabling precision medicine$92097221
997   $aUNINA